585 related articles for article (PubMed ID: 16390273)
21. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis.
Ahmad S; Ahmed A
Endothelium; 2005; 12(1-2):89-95. PubMed ID: 16036320
[TBL] [Abstract][Full Text] [Related]
22. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
23. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
[TBL] [Abstract][Full Text] [Related]
24. The anti-vascular endothelial growth factor receptor-1 monoclonal antibody D16F7 inhibits invasiveness of human glioblastoma and glioblastoma stem cells.
Atzori MG; Tentori L; Ruffini F; Ceci C; Lisi L; Bonanno E; Scimeca M; Eskilsson E; Daubon T; Miletic H; Ricci Vitiani L; Pallini R; Navarra P; Bjerkvig R; D'Atri S; Lacal PM; Graziani G
J Exp Clin Cancer Res; 2017 Aug; 36(1):106. PubMed ID: 28797294
[TBL] [Abstract][Full Text] [Related]
25. Vascular endothelial growth factor signaling implicated in neuroprotective effects of placental growth factor in an in vitro ischemic model.
Du H; Li P; Pan Y; Li W; Hou J; Chen H; Wang J; Tang H
Brain Res; 2010 Oct; 1357():1-8. PubMed ID: 20637183
[TBL] [Abstract][Full Text] [Related]
26. Angiogenic responses of vascular endothelial growth factors in periadventitial tissue.
Bhardwaj S; Roy H; Gruchala M; Viita H; Kholova I; Kokina I; Achen MG; Stacker SA; Hedman M; Alitalo K; Ylä-Herttuala S
Hum Gene Ther; 2003 Oct; 14(15):1451-62. PubMed ID: 14577925
[TBL] [Abstract][Full Text] [Related]
27. Sunitinib inhibits inflammatory corneal lymphangiogenesis.
Detry B; Blacher S; Erpicum C; Paupert J; Maertens L; Maillard C; Munaut C; Sounni NE; Lambert V; Foidart JM; Rakic JM; Cataldo D; Noël A
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3082-93. PubMed ID: 23580490
[TBL] [Abstract][Full Text] [Related]
28. PlGF and sVEGFR-1 in chronic subdural hematoma: implications for hematoma development.
Kalamatianos T; Stavrinou LC; Koutsarnakis C; Psachoulia C; Sakas DE; Stranjalis G
J Neurosurg; 2013 Feb; 118(2):353-7. PubMed ID: 23140147
[TBL] [Abstract][Full Text] [Related]
29. Early signaling by vascular endothelial growth factor and placental growth factor in human bone marrow-derived endothelial cells is mediated by superoxide.
Dhar-Mascareno M; Mascareno E; Golde DW
J Vasc Res; 2009; 46(6):601-8. PubMed ID: 19571580
[TBL] [Abstract][Full Text] [Related]
30. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
Kumazaki K; Nakayama M; Suehara N; Wada Y
Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
[TBL] [Abstract][Full Text] [Related]
31. Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy.
Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patrício B; Quintanilha A; Santos-Silva A
Growth Factors; 2009 Dec; 27(6):345-51. PubMed ID: 19919522
[TBL] [Abstract][Full Text] [Related]
32. Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.
Cai J; Ahmad S; Jiang WG; Huang J; Kontos CD; Boulton M; Ahmed A
Diabetes; 2003 Dec; 52(12):2959-68. PubMed ID: 14633857
[TBL] [Abstract][Full Text] [Related]
33. Neuropilin-1 is required for endothelial cell adhesion to soluble vascular endothelial growth factor receptor 1.
Colotti G; Failla CM; Lacal PM; Ungarelli M; Ruffini F; Di Micco P; Orecchia A; Morea V
FEBS J; 2022 Jan; 289(1):183-198. PubMed ID: 34252269
[TBL] [Abstract][Full Text] [Related]
34. Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.
Donnini S; Machein MR; Plate KH; Weich HA
J Pathol; 1999 Sep; 189(1):66-71. PubMed ID: 10451490
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.
Yao YG; Yang HS; Cao Z; Danielsson J; Duh EJ
FEBS Lett; 2005 Feb; 579(5):1227-34. PubMed ID: 15710418
[TBL] [Abstract][Full Text] [Related]
36. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
37. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR).
Regnault TR; Orbus RJ; de Vrijer B; Davidsen ML; Galan HL; Wilkening RB; Anthony RV
Placenta; 2002; 23(2-3):132-44. PubMed ID: 11945079
[TBL] [Abstract][Full Text] [Related]
38. Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.
Shih SC; Ju M; Liu N; Smith LE
J Clin Invest; 2003 Jul; 112(1):50-7. PubMed ID: 12840058
[TBL] [Abstract][Full Text] [Related]
39. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
[TBL] [Abstract][Full Text] [Related]
40. VEGF-A induces its negative regulator, soluble form of VEGFR-1, by modulating its alternative splicing.
Saito T; Takeda N; Amiya E; Nakao T; Abe H; Semba H; Soma K; Koyama K; Hosoya Y; Imai Y; Isagawa T; Watanabe M; Manabe I; Komuro I; Nagai R; Maemura K
FEBS Lett; 2013 Jul; 587(14):2179-85. PubMed ID: 23711375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
